Kusajili – Centralise les essais cliniques mondiaux

A one-year multicentre, international, randomised, double-blind study with comparison of benfluorex versus an oral anti-diabetic in combination with sulfonylurea administered orally for the treatment of type two diabetes Not provided at time of registration and not expected to be available in the future

• Pays France,
• Organes Aucun
• Spécialités Aucun

Efficacy and safety of the S 05985 combination compared with each individual component: randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients Not provided at time of registration and not expected to be available in the future

• Pays France, Hungary, Latvia, Lithuania, Russian Federation, Ukraine,
• Organes Aucun
• Spécialités Aucun

A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period Not provided at time of registration and not expected to be available in the future

• Pays Australia, Finland, France, South Africa, United Kingdom,
• Organes Aucun
• Spécialités Aucun

Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year Not provided at time of registration and not expected to be available in the future

• Pays France,
• Organes Aucun
• Spécialités Aucun